These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 28229588

  • 1. Intra- and Intersubunit Ion-Pair Interactions Determine the Ability of Apolipoprotein C-II Mutants To Form Hybrid Amyloid Fibrils.
    Todorova N, Zlatic CO, Mao Y, Yarovsky I, Howlett GJ, Gooley PR, Griffin MD.
    Biochemistry; 2017 Mar 28; 56(12):1757-1767. PubMed ID: 28229588
    [Abstract] [Full Text] [Related]

  • 2. Solution Conditions Affect the Ability of the K30D Mutation To Prevent Amyloid Fibril Formation by Apolipoprotein C-II: Insights from Experiments and Theoretical Simulations.
    Mao Y, Todorova N, Zlatic CO, Gooley PR, Griffin MD, Howlett GJ, Yarovsky I.
    Biochemistry; 2016 Jul 12; 55(27):3815-24. PubMed ID: 27311794
    [Abstract] [Full Text] [Related]

  • 3. Hydrogen/Deuterium Exchange and Molecular Dynamics Analysis of Amyloid Fibrils Formed by a D69K Charge-Pair Mutant of Human Apolipoprotein C-II.
    Mao Y, Zlatic CO, Griffin MD, Howlett GJ, Todorova N, Yarovsky I, Gooley PR.
    Biochemistry; 2015 Aug 11; 54(31):4805-14. PubMed ID: 26196342
    [Abstract] [Full Text] [Related]

  • 4. Charge and charge-pair mutations alter the rate of assembly and structural properties of apolipoprotein C-II amyloid fibrils.
    Mao Y, Teoh CL, Yang S, Zlatic CO, Rosenes ZK, Gooley PR, Howlett GJ, Griffin MD.
    Biochemistry; 2015 Feb 17; 54(6):1421-8. PubMed ID: 25609257
    [Abstract] [Full Text] [Related]

  • 5. Polymorphism in disease-related apolipoprotein C-II amyloid fibrils: a structural model for rod-like fibrils.
    Zlatic CO, Mao Y, Todorova N, Mok YF, Howlett GJ, Yarovsky I, Gooley PR, Griffin MDW.
    FEBS J; 2018 Aug 17; 285(15):2799-2812. PubMed ID: 29791776
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
    Wilson LM, Mok YF, Binger KJ, Griffin MD, Mertens HD, Lin F, Wade JD, Gooley PR, Howlett GJ.
    J Mol Biol; 2007 Mar 09; 366(5):1639-51. PubMed ID: 17217959
    [Abstract] [Full Text] [Related]

  • 8. A structural model for apolipoprotein C-II amyloid fibrils: experimental characterization and molecular dynamics simulations.
    Teoh CL, Pham CL, Todorova N, Hung A, Lincoln CN, Lees E, Lam YH, Binger KJ, Thomson NH, Radford SE, Smith TA, Müller SA, Engel A, Griffin MD, Yarovsky I, Gooley PR, Howlett GJ.
    J Mol Biol; 2011 Feb 04; 405(5):1246-66. PubMed ID: 21146539
    [Abstract] [Full Text] [Related]

  • 9. Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils.
    Zlatic CO, Mao Y, Ryan TM, Mok YF, Roberts BR, Howlett GJ, Griffin MD.
    Biochemistry; 2015 Jun 23; 54(24):3831-8. PubMed ID: 26021642
    [Abstract] [Full Text] [Related]

  • 10. A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis.
    Griffin MD, Yeung L, Hung A, Todorova N, Mok YF, Karas JA, Gooley PR, Yarovsky I, Howlett GJ.
    J Mol Biol; 2012 Mar 09; 416(5):642-55. PubMed ID: 22244853
    [Abstract] [Full Text] [Related]

  • 11. Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E.
    Gunzburg MJ, Perugini MA, Howlett GJ.
    J Biol Chem; 2007 Dec 07; 282(49):35831-41. PubMed ID: 17916554
    [Abstract] [Full Text] [Related]

  • 12. Effects of mutation on the amyloidogenic propensity of apolipoprotein C-II(60-70) peptide.
    Todorova N, Hung A, Maaser SM, Griffin MD, Karas J, Howlett GJ, Yarovsky I.
    Phys Chem Chem Phys; 2010 Nov 28; 12(44):14762-74. PubMed ID: 20938536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
    Griffin MD, Mok ML, Wilson LM, Pham CL, Waddington LJ, Perugini MA, Howlett GJ.
    J Mol Biol; 2008 Jan 04; 375(1):240-56. PubMed ID: 18005990
    [Abstract] [Full Text] [Related]

  • 15. High-affinity amphipathic modulators of amyloid fibril nucleation and elongation.
    Ryan TM, Griffin MD, Teoh CL, Ooi J, Howlett GJ.
    J Mol Biol; 2011 Feb 25; 406(3):416-29. PubMed ID: 21185302
    [Abstract] [Full Text] [Related]

  • 16. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation.
    Stewart CR, Wilson LM, Zhang Q, Pham CL, Waddington LJ, Staples MK, Stapleton D, Kelly JW, Howlett GJ.
    Biochemistry; 2007 May 08; 46(18):5552-61. PubMed ID: 17429947
    [Abstract] [Full Text] [Related]

  • 17. Effect of oxidation and mutation on the conformational dynamics and fibril assembly of amyloidogenic peptides derived from apolipoprotein C-II.
    Legge FS, Binger KJ, Griffin MD, Howlett GJ, Scanlon D, Treutlein H, Yarovsky I.
    J Phys Chem B; 2009 Oct 22; 113(42):14006-14. PubMed ID: 19780547
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.